[Bora] Announcement regarding the completion of registration for capital reduction via cancellation of restricted employee shares
Bora Pharmaceuticals announced that on May 20, 2026, it completed the registration for a capital reduction due to the cancellation of restricted employee shares. The paid-in capital has been adjusted to NT$1,277,413,590, with outstanding shares totaling 127,741,359.
📋 Article Processing Timeline
- 📰 Published: May 21, 2026 at 09:00
- 🔍 Collected: May 22, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 22, 2026 at 08:00 (0 min after Collected)
1. Date of approval for capital reduction by competent authority: N/A
2. Date of completion of capital registration change: 115/05/20
3. Impact on financial reports (including differences in paid-in capital and outstanding shares, and impact on net value per share):
(1) Before cancellation of restricted employee shares and capital reduction: The company's paid-in capital was NT$1,277,596,100, with 127,759,610 outstanding shares, and a net value per share of NT$114.03.
(2) After cancellation of restricted employee shares and capital reduction: The company's paid-in capital is NT$1,277,413,590, with 127,741,359 outstanding shares, and a net value per share of NT$114.05.
4. Scheduled share exchange plan: None
5. Expected number of listed common shares after reduction: N/A
6. Expected ratio of listed common shares to total issued common shares after reduction: N/A
7. Countermeasures for low liquidity if the number of listed common shares after reduction is less than 60 million and below 25%: N/A
8. Other matters to be specified:
(1) The net value per share is calculated based on the equity attributable to owners of the parent company in the consolidated financial statements reviewed by an accountant for the most recent period (Q1 of 115).
(2) The company received the approval letter for the registration change from the Department of Commerce, Ministry of Economic Affairs on May 21, 115.
2. Date of completion of capital registration change: 115/05/20
3. Impact on financial reports (including differences in paid-in capital and outstanding shares, and impact on net value per share):
(1) Before cancellation of restricted employee shares and capital reduction: The company's paid-in capital was NT$1,277,596,100, with 127,759,610 outstanding shares, and a net value per share of NT$114.03.
(2) After cancellation of restricted employee shares and capital reduction: The company's paid-in capital is NT$1,277,413,590, with 127,741,359 outstanding shares, and a net value per share of NT$114.05.
4. Scheduled share exchange plan: None
5. Expected number of listed common shares after reduction: N/A
6. Expected ratio of listed common shares to total issued common shares after reduction: N/A
7. Countermeasures for low liquidity if the number of listed common shares after reduction is less than 60 million and below 25%: N/A
8. Other matters to be specified:
(1) The net value per share is calculated based on the equity attributable to owners of the parent company in the consolidated financial statements reviewed by an accountant for the most recent period (Q1 of 115).
(2) The company received the approval letter for the registration change from the Department of Commerce, Ministry of Economic Affairs on May 21, 115.
FAQ
What is the purpose of this capital reduction?
It is intended for the cancellation of restricted employee shares.
What are the main numerical changes?
A reduction in paid-in capital and outstanding shares, resulting in an adjustment to net value per share.
Where can the impact be verified?
It is reflected in the consolidated financial statements for Q1 and the approval letter for the registration change.